Staff Profile

Background 

After completing her BSc in Biomedicine at the University of East Anglia in 2016, Georgie studied for her doctorate in Translational and Clinical Research at Newcastle University, gaining her PhD in 2020. In 2020, Georgie started her role as a research associate in horizon scanning and evidence synthesis which involves horizon scanning and synthesising evidence for a variety of purposes and stakeholders including DHSC and NICE.

About the NIHR Innovation Observatory

The NIHR Innovation Observatory is a world leading health and care innovation scanning centre providing data-driven insights to foster innovation and equitable access to high quality care. They aim to transform health systems and improve population health by providing advanced data-driven insights that foster innovation and equitable access to high quality care. At the core of the Innovation Observatory’s work is the development of data-driven methods to identify, capture and synthesise intelligence on new health innovations. They develop and share cutting edge methods in horizon scanning, building capacity in the systems across the public, voluntary and industry sectors.

They deliver essential intelligence and insights about medicines and MedTech innovation to the National Institute of Health and Care Excellence (NICE), NHS England, the Medicines and Healthcare Products Regulatory Agency (MHRA), the NIHR, the UK Health Security Agency, the Department for Health and Social Care and industry - allowing these organisations to prepare for policies, regulation and frontline delivery for new, emerging and disruptive technologies.

• Articles

  • Thornton C, Lanyi K, Wilkins G, Potter R, Hunter E, Kolehmainen N, Pearson F. Scoping the Priorities and Concerns of Parents: An Infodemiology Study of Posts on Mumsnet and Reddit. Journal of Medical Internet Research 2023, 25, e47849.
  • Sadek J, Inskip A, Woltmann J, Wilkins G, Marshall C, Pokora M, Vedpathak A, Jadrevska A, Craig D, Trenell M. ScanMedicine: An online search system for medical innovation. Contemporary Clinical Trials 2023, 125, 107042.
  • Wilkins GC, Gilmour J, Giannoudaki E, Kirby JA, Sheerin NS, Ali S. Dissecting the Therapeutic Mechanisms of Sphingosine-1-Phosphate Receptor Agonism during Ischaemia and Reperfusion. International Journal of Molecular Sciences 2023, 24(13), 11192.
  • Wilkins GC, Lanyi K, Inskip A, Ogunbayo OJ, Brhlikova P, Craig D. A pipeline analysis of advanced therapy medicinal products. Drug Discovery Today 2023, 28(5), 103549.
  • Marshall C, Lanyi K, Green R, Wilkins GC, Pearson F, Craig D. Using natural language processing to explore mental health insights from UK tweets during the COVID-19 pandemic: infodemiology study. JMIR Infodemiology 2022, 2(1), e32449.
  • Marshall C, Lanyi K, Green R, Wilkins GC, Pandey S, Craig D. Using Twitter to track public opinion in the UK about mental health during the COVID-19 pandemic. Behavioural Science and Public Health Network 2021, 4(2), 4-14.
  • Thompson ER, Bates L, Ibrahim IK, Sewpaul A, Stenberg B, McNeill A, Figueiredo R, Girdlestone T, Wilkins GC, Tingle SJ, Scott WE, Lamos H, Mellor AL, Roobrouck VD, Ting AE, Hosgood SA, Nicholson ML, Fisher AJ, Ali S, Sheerin NS, Wilson CH. Novel delivery of cellular therapy to reduce ischaemia reperfusion injury in kidney transplantation. American Journal of Transplantation 2021, 21(4), 1402-1414.
  • del Molino del Barrio I, Wilkins GC, Meeson A, Ali S, Kirby JA. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. International Journal of Molecular Sciences 2018, 19(11), 3592.

• Conference Proceedings (inc. Abstract)

  • Marshall C, Lanyi K, Green R, Wilkins G, Pandey S, Craig D. Exploring the value of soft-intelligence: a case study using Twitter to track mental health during the COVID-19 pandemic. In: HTAi 2021. 2021, Online: Health Technology Assessment international (HTAi).

• Note

  • del Molino del Barrio I, Wilkins GC, Meeson A, Ali S, Kirby JA. Correction to: Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12 (International Journal of Molecular Sciences, (2018), 19, 11, (3592), 10.3390/ijms19113592). International Journal of Molecular Sciences 2023, 24(23), 17108.